| Curis Lifesciences Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 |
|---|---|---|---|---|
| Debt-Equity Ratio | 1.48 | 5.38 | 0.00 | 0.00 |
| Long Term Debt-Equity Ratio | 0.73 | 2.99 | 0.00 | 0.00 |
| Current Ratio | 1.41 | 1.01 | 0.91 | 0.94 |
| Fixed Assets | 3.07 | 2.23 | 2.27 | 1.55 |
| Inventory | 3.59 | 5.05 | 6.75 | 4.41 |
| Debtors | 5.58 | 3.63 | 4.51 | 3.81 |
| Interest Cover Ratio | 8.45 | 9.45 | 2.16 | 1.75 |
| PBIDTM (%) | 20.46 | 24.47 | 10.16 | 15.16 |
| PBITM (%) | 19.09 | 22.55 | 8.10 | 12.00 |
| PBDTM (%) | 18.20 | 22.08 | 6.41 | 8.34 |
| CPM (%) | 13.80 | 15.61 | 5.53 | 5.22 |
| APATM (%) | 12.44 | 13.70 | 3.47 | 2.06 |
| ROCE (%) | 34.13 | 40.46 | 16.48 | 15.66 |
| RONW (%) | 55.32 | 152.90 | 246.00 | 98.00 |